Vertex Pharmaceuticals Inc. buy Argus
Start price
17.06.24
/
50%
€444.15
Target price
17.06.25
€512.66
Performance (%)
-6.55%
Price
17:24
€415.05
Summary
This prediction is currently active. With a performance of -6.55%, the BUY prediction for Vertex Pharmaceuticals Inc. by Argus is down slightly. This prediction currently runs until 17.06.25. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.772% | -0.772% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Argus for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Argus from $465.00 to $550.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat